Search in:

Cancer Management and Research Volume 10, 2018 - Issue

Submit an article Journal homepage

Open access

130

Views

CrossRef citations to date

Altmetric

Review

Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy

Thomas C WeartMarlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USACorrespondence[email protected]

Kenneth D MillerMarlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA

Charles B Simone 2ndMarlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA

Pages 647-652 | Published online: 03 Apr 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (11)

Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra & Luca Falzone. (2023) Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 15:4, pages 1252.
Crossref

Robert Carroll, Margherita Bortolini, Alan Calleja, Robin Munro, Shiying Kong, Melinda J. Daumont, John R. Penrod, Khalid Lakhdari, Laure Lacoin & Winson Y. Cheung. (2022) Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis. BMC Cancer 22:1.
Crossref

Mohammad Habeeb, Tasneem Abdul Kareem, Kolluru Lakshmi Deepthi, Vidyarani Sujitkumar Khot, You Huay Woon & Sarita Suryabhan Pawar. (2022) Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways. Journal of Drug Delivery Science and Technology 77, pages 103865.
Crossref

Emma Groves, Noor R. Md. Haris & Alastair Greystoke. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 889 904 .

Xi-Feng Jin, Gerald Spöttl, Julian Maurer, Svenja Nölting & Christoph Josef Auernhammer. (2021) Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro. Cancers 13:6, pages 1485.
Crossref

D. A. Andreev, A. A. Zav'yalov, K. I. Polyakova & M. V. Davydovskaуa. (2020) Tyrosine kinase inhibitors in the treatment of advanced lung cancer from example of preferential medicine provision in Moscow city. PULMONOLOGIYA 30:4, pages 463-472.
Crossref

Jrhau Lung, Ming-Szu Hung, Yu-Ching Lin, Yuan Yuan Jiang, Yu-Hung Fang, Ming-Shian Lu, Ching-Chuan Hsieh, Chia-Siu Wang, Feng-Che Kuan, Chang-Hsien Lu, Ping-Tsung Chen, Chieh-Mo Lin, Yen-Li Chou, Chin-Kuo Lin, Tsung-Ming Yang, Fen Fen Chen, Paul Yann Lin, Meng-Jer Hsieh & Ying Huang Tsai. (2020) A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening. Scientific Reports 10:1.
Crossref

Carolyn N. Brown, Daniel J. Atwood, Deepak Pokhrel, Kameswaran Ravichandran, Sara J. Holditch, Sanskriti Saxena, Makoto Miyazaki, Raphael Nemenoff, Mary C.M. Weiser-Evans, Danica Galesic Ljubanovic, Melanie S. Joy & Charles L. Edelstein. (2020) The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice. Cellular Signalling 71, pages 109605.
Crossref

Lin Lin, Dapeng Ding, Xiaoguang Xiao, Bing Li, Penglong Cao & Shijun Li. (2020) Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells. Journal of Cellular and Molecular Medicine 24:12, pages 6822-6832.
Crossref

Linwei Zhang, Lingxin Feng, Hui Cong, Zhuang Yu, Haocheng Wang, Ya Dong & Jing Wang. (2019) Multiple primary malignant neoplasms: A case report and literature review. Oncology Letters.
Crossref

Kumar Prabhash, Suresh H. Advani, Ullas Batra, Bivas Biswas, Anuradha Chougule, Mithua Ghosh, Vamshi Krishna Muddu, T. P. Sahoo & Ashok K. Vaid. (2019) Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing. Advances in Therapy 36:4, pages 766-785.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date